Gene · 2131
Papers1,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer. | PLoS Comput Biol | 2022 | 35263321 | PubTator, text mining | PubMed |
| Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. | Elife | 2022 | 35244537 | PubTator, text mining | PubMed |
| A Case of M-Type Phospholipase A2 Receptor-Associated Membranous Nephropathy With IgG4-Positive Cells Infiltration in the Interstitium. | Clin Med Insights Case Rep | 2022 | 35221739 | PubTator, text mining | PubMed |
| Critical evaluation of cancer risks in glomerular disease. | Transl Oncol | 2022 | 35220046 | PubTator, text mining | PubMed |
| Evolutionarily conserved inhibitory uORFs sensitize Hox mRNA translation to start codon selection stringency. | Proc Natl Acad Sci U S A | 2022 | 35217614 | PubTator, text mining | PubMed |
| Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation. | Int J Mol Sci | 2022 | 35216081 | PubTator, text mining | PubMed |
Regulation of FGF-2, FGF-18 and Transcription Factor Activity by Perlecan in the Maturational Development of Transitional Rudiment and Growth Plate Cartilages and in the Maintenance of Permanent Cartilage Homeostasis. | Int J Mol Sci | 2022 | 35216048 | PubTator, text mining | PubMed |
| Clinical survey of a pedigree with hereditary multiple exostoses and identification of EXT‑2 gene deletion mutation. | Mol Med Rep | 2022 | 35211766 | PubTator, text mining | PubMed |
| Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network. | Cancers (Basel) | 2022 | 35205681 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis. | Genes (Basel) | 2022 | 35205284 | PubTator, text mining | PubMed |
| Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. | Sci Rep | 2022 | 35194125 | PubTator, text mining | PubMed |
| Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis and survival. | Orphanet J Rare Dis | 2022 | 35193636 | PubTator, text mining | PubMed |
| Head kinematics in patients with neck pain compared to asymptomatic controls: a systematic review. | BMC Musculoskelet Disord | 2022 | 35172799 | PubTator, text mining | PubMed |
| Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma. | Int J Mol Sci | 2022 | 35163019 | PubTator, text mining | PubMed |
| Benign Bone Tumors: An Overview of What We Know Today. | J Clin Med | 2022 | 35160146 | PubTator, text mining | PubMed |
| A dominant negative splice variant of the heparan sulfate biosynthesis enzyme NDST1 reduces heparan sulfate sulfation. | Glycobiology | 2022 | 35137078 | Swiss-Prot, curated | PubMed |
| Genetic and functional analyses detect an EXT1 splicing pathogenic variant in a Chinese hereditary multiple exostosis (HME) family. | Mol Genet Genomic Med | 2022 | 35106951 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
| Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier. | Mol Genet Genomics | 2022 | 35103870 | PubTator, text mining | PubMed |
| Osteochondroma Arising From the Inferior Articular Process of the Lumbar Spine in a Geriatric Patient: A Case Report and Literature Review. | Geriatr Orthop Surg Rehabil | 2022 | 35096462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2131/papers?page=22